Immunoglobulin

Hyqvia

BrazilAuthorisedAuthorised 29 Jun 2026

In other countries

The same active substances on other registers, the same brand first.

A T G Fresenius "Solution"Taiwan · 注射劑 · 海喬國際股份有限公司Same form
CuvitruCanada · 200 MG / ML · Solution · Takeda Canada INCSame substance
GamastanCanada · 18 % · Solution · Grifols Therapeutics LLCSame substance
Gammagard LiquidCanada · 10 % · Solution · Takeda Canada INCSame substance
Gammagard S/D for InjectionSingapore · 48-56 mg/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same substance
OCTAGAM SOLUTION FOR INFUSION 50 mg/mlSingapore · 50 mg/ml · injection · Wellchem Pharmaceuticals Pte LTDSame substance
PENTAGLOBIN INJECTION 50 mg/mlSingapore · 50 mg/ml · injection · Grifols Asia Pacific Pte. LTD.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Immunoglobulin

Hyqvia

BrazilAuthorisedAuthorised 29 Jun 2026

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Immunoglobulin
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 29 Jun 2026
Registration: 126270022
Marketing authorisation holder: Takeda Farmaceutica Brasil Ltda
Procedure: Registered

Atg FreseniusImmunoglobulinBrazilCancelled

BeriglobinaImmunoglobulinBrazilCancelled

Endobulin KiovigImmunoglobulinBrazilCancelled

Gamimune N 5%ImmunoglobulinBrazilCancelled

HyqviaImmunoglobulinBrazilCancelled

Ig Vena N I VImmunoglobulinBrazilCancelled